2 results
Approved WMORecruiting
To study the safety and efficacy of mitapivat in the treatment of adult subjects with sickle cell disease.
Approved WMOPending
The primary, secondary and exploratory objectives of the study are as follows:Part APrimary:• To evaluate the safety and tolerability of the different GEH200520 Injection mass doses and a fixed dose of GEH200521 (18F) Injection when administered…